# reload+after+2024-01-23 19:43:46.772005
address1§40 Manning Road
city§Billerica
state§MA
zip§01821
country§United States
phone§978 663 3660
fax§978 663 5585
website§https://www.bruker.com
industry§Medical Devices
sector§Healthcare
longBusinessSummary§Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.
fullTimeEmployees§8525
companyOfficers§[{'maxAge': 1, 'name': 'Dr. Frank H. Laukien Ph.D.', 'age': 63, 'title': 'Chairman, CEO & President', 'yearBorn': 1960, 'fiscalYear': 2022, 'totalPay': 1815797, 'exercisedValue': 3253255, 'unexercisedValue': 3711934}, {'maxAge': 1, 'name': 'Mr. Gerald N. Herman', 'age': 65, 'title': 'Executive VP & CFO', 'yearBorn': 1958, 'fiscalYear': 2022, 'totalPay': 858088, 'exercisedValue': 0, 'unexercisedValue': 1158492}, {'maxAge': 1, 'name': 'Dr. Mark R. Munch Ph.D.', 'age': 61, 'title': 'Corporate Executive VP and President of Bruker Nano Group & Corporate', 'yearBorn': 1962, 'fiscalYear': 2022, 'totalPay': 1439963, 'exercisedValue': 0, 'unexercisedValue': 5231391}, {'maxAge': 1, 'name': 'Mr. Juergen  Srega', 'age': 68, 'title': 'President of Bruker CALID Group & Bruker Daltonics Division', 'yearBorn': 1955, 'fiscalYear': 2022, 'totalPay': 646991, 'exercisedValue': 0, 'unexercisedValue': 1797473}, {'maxAge': 1, 'name': 'Dr. Falko  Busse Ph.D.', 'age': 56, 'title': 'President of Bruker BioSpin Group', 'yearBorn': 1967, 'fiscalYear': 2022, 'totalPay': 763337, 'exercisedValue': 0, 'unexercisedValue': 1224745}, {'maxAge': 1, 'name': 'Mr. Justin Joseph Ward', 'title': 'Senior Director of Investor Relations & Corporate Development', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. J. Brent Alldredge J.D.', 'age': 48, 'title': 'General Counsel & Secretary', 'yearBorn': 1975, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Stacey  Desrochers', 'title': 'Treasurer & Director of Investor Relations', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Burkhard  Prause Ph.D.', 'age': 56, 'title': 'President and CEO of Bruker Energy & Supercon Technologies, Inc.', 'yearBorn': 1967, 'fiscalYear': 2022, 'totalPay': 595963, 'exercisedValue': 0, 'unexercisedValue': 31800}]
auditRisk§7
boardRisk§6
compensationRisk§3
shareHolderRightsRisk§4
overallRisk§5
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
dividendRate§0.2
dividendYield§0.0029
exDividendDate§1701302400
payoutRatio§0.0926
fiveYearAvgDividendYield§0.31
beta§1.17
priceToSalesTrailing12Months§3.4096923
currency§USD
dateShortInterest§1702598400
forwardEps§2.76
pegRatio§2.51
exchange§NMS
quoteType§EQUITY
shortName§Bruker Corporation
longName§Bruker Corporation
firstTradeDateEpochUtc§965395800
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§ab422d97-7e2c-351a-832e-83c073c93091
gmtOffSetMilliseconds§-18000000
targetHighPrice§86.0
targetLowPrice§57.0
targetMeanPrice§73.25
targetMedianPrice§74.02
recommendationMean§2.1
recommendationKey§buy
numberOfAnalystOpinions§12
quickRatio§0.969
earningsGrowth§0.017
grossMargins§0.51469004
ebitdaMargins§0.20753
trailingPegRatio§None
